BUZZ-Tekmira Pharmaceuticals: Ebola treatment for U.S. Defense

Fri Nov 7, 2014 8:23am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up 6 pct at $16.72 premarket

** Says on Thursday U.S. Department of Defense exercised an option for the company to make 500 courses of its experimental treatment for Ebola

** Up to Thursday's close, stock had fallen about 25 pct since Sept. 30, when the first patient was diagnosed with Ebola in the United States

** TAKE A LOOK-World On Alert To Contain Ebola Outbreak